Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Madhu V. Midathada
Observed names:
M. Midathada,
M. V. Midathada,
MADHU V MIDATHADA,
Madhu Midathada
Institution:
Nebraska Hematology-Oncology
Observed institutions:
University of Arkansas Medical Center,
Central Arkansas Veterans Healthcare System,
Nebraska Hematology-Oncology,
University of Arkansas for Medical Sciences
OpenAlex ID:
A5003513632
Thiazolidinediones and the Risk of Lung, Prostate, and Colon Cancer in Patients With Diabetes
2007
·
Rangaswamy Govindarajan
, Luke Ratnasinghe
, et al.
·
Journal of Clinical Oncology
·
336
PDF
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
2019
·
Ignace Vergote
, Giovanni Scambia
, et al.
·
The Lancet Oncology
·
87
PDF
Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis
2019
·
Susan R. Kahn
, Jim A. Julian
, et al.
·
Journal of Vascular Surgery Venous and Lymphatic Disorders
·
84
Recombinant Factor VIIa in the Treatment of Bleeding
2004
·
Madhu V. Midathada
, Paulette Mehta
, et al.
·
American Journal of Clinical Pathology
·
53
PDF
Natural T, γδ, and NK Cells in Mycobacterial,Salmonella,and Human Immunodeficiency Virus Infections
2000
·
Janine Jason
, Ian Buchanan
, et al.
·
The Journal of Infectious Diseases
·
38
Breast Cancer Subtype Influences the Accuracy of Predicting Pathologic Response by Imaging and Clinical Breast Exam After Neoadjuvant Chemotherapy
2016
·
ASHLEY R WALDREP
, ERIC J AVERY
, et al.
·
Anticancer Research
·
10
PDF
Hodgkin lymphoma presenting as paraneoplastic cerebellar degeneration: A case report
2025
·
Anisha Kadubandi
, Madhu Midathada
, et al.
·
SAGE Open Medical Case Reports
·
2
Role of androgen deprivation in EGFR and Her-2/neu gene expression patterns in prostate cancer
2004
·
M. V. Midathada
, R. Dennis
, et al.
·
Journal of Clinical Oncology
·
1
Toward understanding toxicity over time (ToxT) in myeloma cooperative group trials: Feasibility of a novel longitudinal adverse event analysis in ECOG-ACRIN E1A06.
2018
·
Susanna J. Jacobus
, Paul J. Novotny
, et al.
·
Journal of Clinical Oncology
Association between the use of thiazolidinediones and the risk of cancer in diabetic patients
2005
·
R. Govindarajan
, L. Ratnasinghe
, et al.
·
Journal of Clinical Oncology
Influence of demographics on patient refusal to enroll into clinical trials
2005
·
M. V. Midathada
, T. Spencer
, et al.
·
Journal of Clinical Oncology
Ocular melanoma versus ocular metastasis: a diagnostic dilemma.
2005
·
Madhu Midathada
, Ammar Safar
, et al.
·
PubMed
Show more works
View as search
Works count:
12
Citation count:
611
H-index:
6
I10-index:
6
Year
Topic
Type
